Gordon joined Cavendish Corporate Finance in 2009 to lead coverage of the healthcare sector. Gordon has eleven years experience of advising healthcare companies, both public and private, on a range of transactions and financial products.
Gordon studied Pharmacology at the University of Aberdeen followed by a PhD in Pharmacology at Cambridge University.
Gordon qualified as an ACA with Arthur Andersen where he worked in the Healthcare Corporate Finance team in both London and New York. Gordon spent five years in Citigroup's healthcare team working in both New York and London. Gordon led the life science team at Deloitte Corporate Finance and Healthcare team at ING prior to joining Cavendish.
The Cavendish Chemicals Group focuses on the sale of businesses in the chemical and related sectors, both manufacturers & distributors.
The Cavendish Healthcare Group focuses on the sale of businesses in the healthcare sector.
Linda , Gordon and the team at Cavendish were superb. They managed a competitive sale process and generated interest from international buyers from the broad media and healthcare sectors.
Dr Wayne Phillips, CEO of Double Helix
Cavendish is delighted to have advised on the sale of Double Helix Bio-Technology Development Ltd (“ Double Helix”), a leading, global provider of Market Research and Market Access services to the...
YorkTest, Europe's leading food intolerance (delayed food allergy) testing company, has been acquired by Ingemino Limited, a newly established company formed by successful entrepreneurs Keith Tozzi...